Combination of vascular disrupting agents and ionizing radiation
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Reference113 articles.
1. The role of radiotherapy in cancer treatment: estimating optimal utilization from a review of evidence-based clinical guidelines;Delaney;Cancer,2005
2. Strategies to improve radiotherapy with targeted drugs;Begg;Nature Reviews Cancer,2011
3. Recent advances in radiotherapy;Bhide;BMC Medicine,2010
4. Tumor angiogenesis: therapeutic implications;Folkman;New England Journal of Medicine,1971
5. Vascular occlusion and tumour cell death;Denekamp;European Journal of Cancer and Clinical Oncology,1983
Cited by 40 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. SKLB-14b, a novel oral microtubule-destabilizing agent based on hydroxamic acid with potent anti-tumor and anti-multidrug resistance activities;Bioorganic Chemistry;2022-11
2. Vascular disrupting agent-induced amplification of tumor targeting and prodrug activation boosts anti-tumor efficacy;Science China Chemistry;2022-09-13
3. Demonstrating Tumor Vascular Disrupting Activity of the Small-Molecule Dihydronaphthalene Tubulin-Binding Agent OXi6196 as a Potential Therapeutic for Cancer Treatment;Cancers;2022-08-30
4. CKD-516 potentiates the anti-cancer activity of docetaxel against epidermal growth factor receptor tyrosine kinase inhibitor-resistant lung cancer;Toxicological Research;2022-08-22
5. Microtubule Targeting Agents in Disease: Classic Drugs, Novel Roles;Cancers;2021-11-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3